ibandronic acid

Italy

Drugs containing this active substance

  • BAXOGAR

    Baxogar is prescribed to treat postmenopausal osteoporosis in women at high risk of fractures. The drug helps to prevent bone loss and increase bone mass, reducing the possibility of spinal fractures.

    Form: tablets, film-coated

    Active substance Dosage
    ibandronic acid -

    ATC: M05BA06

    Manufacturer: PHARMACARE S.R.L.

  • This medicine is used for several conditions: in adults with breast cancer that has spread to the bones, it helps prevent fractures and other bone problems that might require surgery or radiotherapy; it can also be prescribed for high calcium levels in the blood caused by cancer. In other cases, it is used to treat postmenopausal osteoporosis in women at high risk of fractures.

    Form: solution for infusion, concentrate

    Active substance Dosage
    ibandronic acid -

    ATC: M05BA06

    Manufacturer: ACCORD HEALTHCARE, S.L.U.

  • It is prescribed to treat postmenopausal osteoporosis in women with a high risk of fractures. The drug helps to block bone loss and increase bone mass, reducing the possibility of spinal fractures.

    Form: tablets, film-coated

    Active substance Dosage
    ibandronic acid -

    ATC: M05BA06

    Manufacturer: LABORATORI ALTER S.R.L.

  • It is prescribed to treat postmenopausal osteoporosis in women at high risk of fractures. The drug helps to block bone loss and increase bone mass, reducing the risk of spinal fractures.

    Form: tablets, film-coated

    Active substance Dosage
    ibandronic acid -

    ATC: M05BA06

    Manufacturer: DOC GENERICI SRL

  • It is prescribed to treat osteoporosis in women with a high risk of fractures. The drug helps to block bone loss and increase bone mass, reducing the possibility of spinal fractures.

    Form: tablets, film-coated

    Active substance Dosage
    ibandronic acid -

    ATC: M05BA06

    Manufacturer: SANDOZ S.P.A.

  • This medicine is prescribed to treat postmenopausal osteoporosis in women at high risk of fractures, or for adults with breast cancer that has spread to the bones (bone metastases), with the aim of preventing fractures and other bone problems.

    Form: tablets, film-coated

    Active substance Dosage
    ibandronic acid -

    ATC: M05BA06

    Manufacturer: TECNIGEN S.R.L.

  • It is prescribed to treat postmenopausal osteoporosis in women at high risk of fractures. The drug helps to counteract bone loss and can decrease the possibility of spinal fractures.

    Form: tablets, film-coated

    Active substance Dosage
    ibandronic acid -

    ATC: M05BA06

    Manufacturer: ZENTIVA ITALIA S.R.L.